Cargando…

Incidence of Diabetic Ketoacidosis in Hospitalized COVID19 Patients With Type 2 Diabetes

Introduction: Diabetes is a disease of persistent hyperglycemia with a devastating complication and even death if left untreated. Morbidity and mortality often increased for any condition among patients with diabetes. Diabetic ketoacidosis (DKA) is an acute and life-threatening complication of diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almistehi, Wael Mohammad, Alturki, Abdulrahman Mohammed, Bukhari, Bashear Adnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090118/ http://dx.doi.org/10.1210/jendso/bvab048.706

Ejemplares similares

Diabetic Ketoacidosis With Alpelisib
por: Jeun, Rebecca, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis
por: Espinosa, Luis Borges, et al.
Publicado: (2021)

SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020)

Diabetic Ketoacidosis and Acute Pancreatitis in Covid-19 Setting
por: Srinivasan, Aswin, et al.
Publicado: (2021)

Complications and Outcomes in Patients With Diabetic Ketoacidosis and COVID19
por: Hwang, Patricia, et al.
Publicado: (2021)

MON-128 Pneumomediastinum in Diabetic Ketoacidosis
por: Poudel, Resham, et al.
Publicado: (2019)

Rates and Predictors of 30-Day Readmission in Adults with Type 1 Diabetes Hospitalized for Diabetic Ketoacidosis in the US: A Nationwide Study
por: Shaka, Hafeez, et al.
Publicado: (2021)

The Perfect Storm: Rapid Progression of Diabetic Ketoacidosis in Pediatric Diabetes in the Setting of COVID-19
por: Modarelli, Rachel, et al.
Publicado: (2021)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

SAT-670 The Perfect Storm for Diabetic Ketoacidosis
por: Abushamat, Layla A, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

The Peruvian Experience: New-Onset Diabetes Presenting With Diabetic Ketoacidosis in Patients With COVID19 Infections
por: Ramos-Yataco, Anthony, et al.
Publicado: (2021)

Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated With COVID 19
por: Naranjo, José Martín Alanís, et al.
Publicado: (2021)

Ketogenic Diet Induced Severe Diabetic Ketoacidosis in an Elderly With Undiagnosed Diabetes
por: Lertdetkajorn, Khemaporn, et al.
Publicado: (2021)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

MON-614 Degree of Diabetes Control Determines the Admission Severity of Diabetic Ketoacidosis
por: Grover, Harshwant, et al.
Publicado: (2020)

SAT-138 Predictors and Health Care Expenditures Associated with Recurrent Diabetic Ketoacidosis Admissions in Adults with Type 1 Diabetes
por: Everett, Estelle, et al.
Publicado: (2019)

MON-700 Protective Effects of Smoking? Improved In-Hospital Mortality in Smokers Admitted for Diabetic Ketoacidosis
por: Nasserifar, Shabnam, et al.
Publicado: (2020)

MON-615 Retrospective Analysis of the Contribution of Cannabis Usage to Diabetic Ketoacidosis at an Urban Teaching Hospital
por: Kha, Christine K, et al.
Publicado: (2020)

MON-151 Hypertriglyceridemia and Acute Pancreatitis Leading to Ketoacidosis in a Patient with Type 2 Diabetes
por: Fishel, Heather, et al.
Publicado: (2019)

MON-143 Diabetic Ketoacidosis Confounding Diagnosis of Acromegaly with Microadenoma
por: Yakubov, Mikhail, et al.
Publicado: (2019)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

SUN-700 Fournier’s Gangrene and Diabetic Ketoacidosis Caused by Canagliflozin
por: Stamatiades, George Alexiades, et al.
Publicado: (2020)

A Case of Euglycemic Diabetic Ketoacidosis Following Canagliflozin Therapy
por: Tuna, Kubra M, et al.
Publicado: (2021)

The Troublesome Triad: Hypertriglyceridemia-Induced Acute Pancreatitis in Diabetic Ketoacidosis
por: Rashid, Hytham, et al.
Publicado: (2021)

Comparing Disease Severity: Diabetic Ketoacidosis in Local and Tourist Children With New-Onset Diabetes Mellitus
por: Hinds, Autumn, et al.
Publicado: (2021)

SAT-672 An Unusual and Enigmatic Etiology for Diabetic Ketoacidosis: Safety Needles
por: Modi, Ankur, et al.
Publicado: (2020)

Mesenteric Ischemia in a Young Man With the First Presentation of Diabetic Ketoacidosis
por: Esper, Layal
Publicado: (2021)

SUN-173 Nivolumab-Induced Fulminant Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Patient with Melanoma
por: Parikh, Sahil, et al.
Publicado: (2019)

MON-LB124 Euglycemic Diabetic Ketoacidosis on Initiation of Ertugliflozin in a Patient With Type 2 Diabetes Mellitus Precipitated by a Ketogenic Diet
por: Richstein, Ryan, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis Post Bariatric Surgery in Type II DM in the Setting of SGLT2-Inhibitor Use
por: Alfares, Khalid, et al.
Publicado: (2021)

SUN-615 Does Patient Location (Urban or Rural) Influence Risk Factors and Incidence Rate for 30-Day Readmission for Diabetic Ketoacidosis?
por: Varghese, Ron Thomas, et al.
Publicado: (2020)

SAT-682 Unusual Presentation of Diabetic Ketoacidosis Associated with Hypernatremia in Adult Patient
por: Aljaberi, Asma Khaled, et al.
Publicado: (2020)

Diabetic Ketoacidosis Presenting in Major Thalassemia With Pancreatic Hemosiderosis: A Case Report
por: Mulyadi, Calvin Kurnia, et al.
Publicado: (2021)

SUN-172 Diabetic Ketoacidosis Precipitated by Treatment with PD-1 Inhibitor: A Rare Immune Related Adverse Event
por: Qureshi, Mohammed
Publicado: (2019)

MON-LB126 A Benign and Favorable Diagnosis: Glycogen Hepatopathy Causing Transient Transaminitis During Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
por: Yau, Alice, et al.
Publicado: (2020)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

Patient-Specific Risk Factors and Clinical Correlates of Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Co-Transporter-2 Inhibitors
por: Somagutta, Manoj Reddy, et al.
Publicado: (2021)

SUN-LB036 Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus
por: Abid, Haisam, et al.
Publicado: (2019)

MON-127 Euglycemic Diabetic Ketoacidosis: A Rare Complication of a Common Disease
por: Kazi, Fatima, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b4m2lj37f1kamrlf3mkahi6mtb